Patheon — Q3 2012 Earnings Presentation
13 slides from Patheon's earnings presentation, Sep 13, 2012
Slide 1: Fiscal 2012 Third Quarter Results
Patheon Fiscal 2012 Third Quarter Results September 13, 2012 Exhibit 99.2
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking statements or information which reflect our expectations regarding possible events, conditions, our future growth, results of operations, performance, and business prospects and opportunities. All statements, other than statements
Slide 3: Agenda
Agenda • Highlights • Financial results • Transformation update • Conclusion
Slide 4: Third Quarter Highlights
Third Quarter Highlights 18 percent revenue growth 115 percent gross profit – 236 percent Adjusted EBITDA increases Increasing revenue guidance – exceeding $735 million Transformation continues to yield benefits
Slide 5: Continued Quarterly Growth
Continued Quarterly Growth Revenue (U.S. $ in millions) 172.7 181.6 153.9 181.5 203.7 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 18% yr-yr revenue growth
Slide 6: Strong Conversion To Gross Profit
Strong Conversion To Gross Profit Gross Profit (U.S. $ in millions) 115% yr-yr gross profit growth 25.8 33.5 14.4 34.0 55.5 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012
Slide 7: Solid Progress With Adjusted EBITDA
Solid Progress With Adjusted EBITDA Adjusted EBITDA (U.S. $ in millions) Adjusted EBITDA Excluding Certain Items (U.S. $ in millions) -15 -5 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 -15 -5 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 10.3 14.5 (9.2) 9.7 34.6 12.8 21.0 (2.9) 15.7 35.6
Slide 8: Sufficient Liquidity to Manage Business
Sufficient Liquidity to Manage Business 39.5 33.4 32.5 19.6 35.4 98.2 94.9 93.8 60.1 63.0 $ in Millions 137.7 128.3 126.3 79.7 98.4 - 20.0 40.0 60.0 80.0 100.0 120.0 140.0 160.0 3Q11 4Q11 1Q12 2Q12 3Q12 Cash Availability Liquidity
Slide 9: Summary Financial Results
Summary Financial Results Three months ended July 31, Statement of Operations (in millions of U.S. dollars) $ $ Revenues 203.7 172.7 Gross Profit 55.5 25.8 Selling, general and administrative expenses 29.9 31.7 Operating income (loss) 25.5 (7.7) Income before discontinued operations 15.5 0.6 Adjuste
Slide 10: Strategic Roll Out is Advancing
Strategic Roll Out is Advancing STRENGTHEN CORE OPERATIONS ENTER LOGICAL ADJACENCIES DRIVE INDUSTRY CONSOLIDATION SELL BUSINESS DIFFERENTLY • OE programs have de-bottlenecked revenue capacity • Drove gross profit and adjusted EBITDA increased in Q3 • Clinical packaging business sale • Rolled-out Sol
Slide 11: Summary
Summary • Growing revenues and improving margins • Transformation activities continue to benefit our financial results and are on track • Balance sheet and liquidity are good • Raising top-line guidance
Slide 12: Thank You
Thank You
Slide 13: Adjusted EBITDA and Adjusted EBITDA Excluding Certain Items
Appendix Adjusted EBITDA and Adjusted EBITDA Excluding Certain Items (unaudited) Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 (in millions of U.S. dollars) $ $ $ $ $ Income (loss) before discontinued operations 0.6 (9.8) (19.3) (79.6) 15.5 Depreciation and amortization 12.6 12.2 10.6 10.8 9.3 Repositioni